Renaissance BioScience Corp., a global leader in bioengineered yeast for agriculture, food, environmental, and energy industries, announced the grant of a Mexican patent for its innovative yeast-based platform technology that enables low-cost production and effective delivery of RNA. This is the third patent issued for the company's RNA technology, following earlier grants in China and Australia, with additional jurisdictions pending. The new patent expands Renaissance's robust IP portfolio of issued and pending patents for yeast-based technologies across multiple end-use markets.
The company's most advanced commercial application of this RNA production and delivery system is a suite of RNAi-based biopesticide products that provide precise, targeted pest control. These products offer a strong environmental safety profile compared with broad-spectrum chemical pesticides, while maintaining competitive production costs at scale. Equally importantly, the technology integrates smoothly into current farming practices and equipment, making it a viable alternative for growers seeking sustainable solutions.
Dr. John Husnik, Renaissance's CSO and Office of the CEO, commented on the new patent: "This patent from the Mexican office confirms the novelty and importance of our yeast-based RNA technology for producing, protecting and delivering next-generation RNA bioactive molecules. In addition to biopesticides, this platform offers exciting opportunities across a wide range of multi-billion-dollar commercial markets."
The Mexican patent strengthens Renaissance's position in the global biopesticide market, which is projected to grow significantly as farmers and regulators seek alternatives to chemical pesticides. RNA interference (RNAi) technology offers a mode of action that can be highly specific to target pests, reducing off-target effects on beneficial insects and the environment. Renaissance's yeast-based production system aims to overcome previous cost barriers associated with RNA manufacturing, potentially making RNAi biopesticides economically competitive with traditional chemical products.
Beyond biopesticides, the platform technology holds promise for applications in animal health, human therapeutics, and industrial processes. The company continues to pursue patent protection in other key markets to safeguard its intellectual property and support commercialization efforts. For more information, visit Renaissance BioScience.
